Meeder Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Sell
4,027
-67
-2% -$22K 0.05% 252
2025
Q4
$1.44M Sell
4,094
-127
-3% -$42.9K 0.06% 212
2025
Q3
$1.36M Sell
4,221
-80
-2% -$24.9K 0.06% 212
2025
Q2
$1.67M Sell
4,301
-313
-7% -$126K 0.09% 169
2025
Q1
$2.01M Buy
4,614
+769
+20% +$309K 0.12% 140
2024
Q4
$1.42M Sell
3,845
-192
-5% -$80.3K 0.09% 174
2024
Q3
$2.1M Sell
4,037
-11
-0.3% -$5.88K 0.14% 121
2024
Q2
$2.19M Buy
4,048
+937
+30% +$495K 0.16% 115
2024
Q1
$1.61M Buy
3,111
+83
+3% +$41.3K 0.16% 106
2023
Q4
$1.43M Buy
3,028
+16
+0.5% +$7.4K 0.16% 108
2023
Q3
$1.31M Sell
3,012
-685
-19% -$311K 0.16% 106
2023
Q2
$1.64M Sell
3,697
-376
-9% -$173K 0.18% 100
2023
Q1
$1.87M Sell
4,073
-339
-8% -$161K 0.22% 83
2022
Q4
$2.26M Buy
+4,412
New +$2.24M 0.29% 64

Other funds holding ELV

Meeder Advisory Services's ELV Position: Q1 2026 in Review

Meeder Advisory Services reduced its Elevance Health (ELV) stake by 1.6% in Q1 2026, selling an estimated $22K and leaving 4,027 shares worth $1.18M. The position accounts for 0.05% of the portfolio, ranked #252.

Meeder Advisory Services first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.26M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Meeder Advisory Services held 4,027 shares of Elevance Health worth $1.18M as of Q1 2026.
  • Meeder Advisory Services sold 67 Elevance Health shares in Q1 2026, an estimated $22K.
  • Elevance Health made up 0.05% of Meeder Advisory Services's portfolio in Q1 2026, its #252 holding.
  • Meeder Advisory Services first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • Meeder Advisory Services's Elevance Health position peaked at $2.26M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.